| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.28 | 3e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 0.0008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |